SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 52 filers reported holding SINOVAC BIOTECH LTD in Q1 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $7,053,000 | -21.3% | 1,250,546 | +0.5% | 0.02% | -16.0% |
Q1 2014 | $8,958,000 | +24.2% | 1,244,206 | +5.6% | 0.02% | +38.9% |
Q4 2013 | $7,213,000 | -18.1% | 1,178,606 | -20.0% | 0.02% | -21.7% |
Q3 2013 | $8,811,000 | -14.7% | 1,473,343 | -43.9% | 0.02% | -11.5% |
Q2 2013 | $10,325,000 | – | 2,627,231 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Neumann Advisory Hong Kong Ltd | 402,844 | $3,005,000 | 1.62% |
Sapphire Star Partners LP | 96,992 | $723,000 | 0.75% |
Orbimed Advisors | 2,839,500 | $21,183,000 | 0.25% |
Yorktown Management & Research Co Inc | 64,645 | $482,000 | 0.14% |
NAVELLIER & ASSOCIATES INC | 31,865 | $238,000 | 0.03% |
Renaissance Technologies | 5,172,930 | $41,625,000 | 0.02% |
Freedom Investment Management, Inc. | 41,828 | $312,000 | 0.02% |
Spark Investment Management LLC | 39,600 | $295,000 | 0.02% |
Financial Gravity Asset Management, Inc. | 460 | $3,000 | 0.00% |
SG Americas Securities, LLC | 24,021 | $179,000 | 0.00% |